A Johns Hopkins study suggests the parathyroid hormone may stop chronic back pain at its source by reversing nerve growth in ...
A breakthrough diagnostic test is changing the way surgeons operate on patients for hyperparathyroidism, a condition in which the blood's calcium level is elevated from one or more diseased or ...
Parathyroid hormone (PTH) monitoring that can differentiate between oxidized and nonoxidized forms of the substance is expected to improve the treatment of patients with end-stage renal disease (ESRD) ...
November 5, 2007 (San Francisco) ā A number of assays that test for intact parathyroid hormone levels (iPTH) are not appropriate for use with the National Kidney Foundation's Kidney Disease Outcomes ...
TAMPA, Fla. (WFLA) ā Doctors are raising awareness about a disease that often comes with vague symptoms. Parathyroid disease is diagnosed in hundreds of thousands of Americans every year. The disorder ...
We describe two cases of acquired parathyroid hormone (PTH) resistance consequent to the development of serum PTH type 1 receptor (PTH1R) autoantibodies, which block PTH binding and signaling. Both ...
Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study. Patient-derived parathyroid organoids (PTOs) ...
Orlando M. Gutiérrez, MD The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. HOW TO TAKE THE POST-TEST: To obtain CME ...
Parathyroid carcinoma is a rare malignancy, representing 0.005% of all cancers and 0.5%-1% of all parathyroid disorders. Parathyroid carcinoma occurs equally in males and females, as opposed to ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results